Scarica l'app Stockscreener
35.45
0.20%
-0.07
Dopo l'orario di chiusura:
35.48
0.03
+0.08%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché VKTX Giù?
Forum
Previsione
Viking Therapeutics Inc Borsa (VKTX) Ultime notizie
VKTX stock rises after-hours: CNBC flags Viking as likely buyout target this year as big pharma hunts next GLP-1 winner - MSN
Viking Therapeutics, Inc. (VKTX) surpasses market returns: Some facts worth knowing - MSN
Viking Therapeutics (VKTX) barely up since Jim Cramer advised selling the stock - MSN
Viking Therapeutics, Inc. (VKTX) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic? - Yahoo! Finance Canada
Viking Therapeutics, Inc. (VKTX) Surpasses Market Returns: Some Facts Worth Knowing - Yahoo Finance
Viking Therapeutics rises after Q4 updates on obesity therapy - MSN
(VKTX) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
VKTX finishes enrollment in second late-stage study on obesity drug - MSN
Is It Too Early To Consider Viking Therapeutics (VKTX) A Bargain After Recent Pullback? - Yahoo Finance
Viking Therapeutics (VKTX) Barely Up Since Jim Cramer Advised Selling The Stock - Insider Monkey
Viking Therapeutics, Inc. (VKTX) latest stock news and headlines - Yahoo Finance UK
20 Stocks Jim Cramer Wanted You To Sell & Immediately Get Out Of - Insider Monkey
Viking Therapeutics to Attend Investor Conferences - Intellectia AI
Viking Therapeutics to Participate at Upcoming Investor Conferences - PR Newswire
MH & Associates Securities Management Corp ADV Buys New Stake in Viking Therapeutics, Inc. - National Today
Viking Therapeutics, Inc. (VKTX) stock price, news, quote and history - Yahoo Finance Singapore
Viking Therapeutics (VKTX) Is Up 7.0% After Completing Enrollment In Key VANQUISH-2 Obesity Trial - Sahm
Viking Therapeutics, Inc. (VKTX) Shares Fall as Broader Market Rises: Important Details - Bitget
Viking Therapeutics, Inc. (VKTX) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Viking Therapeutics, Inc. (VKTX) Latest Stock News & Headlines - Yahoo Finance
Viking Therapeutics Inc (1VT.HM) Interactive Stock Chart - Yahoo! Finance Canada
Viking Therapeutics, Inc. (VKTX) interactive stock chart - Yahoo Finance Singapore
Where Will Viking Therapeutics Stock Be in 10 Years? - The Globe and Mail
Where Will Viking Therapeutics Stock Be in 10 Years? - The Motley Fool
Did VK2735’s VANQUISH-2 Enrollment Milestone Just Reframe Viking Therapeutics' (VKTX) Obesity Drug Ambitions? - Yahoo Finance
VKTX Stock Rises After-Hours: CNBC Flags Viking As Likely Buyout Target This Year As Big Pharma Hunts Next GLP-1 Winner - stocktwits.com
Viking Therapeutics (VKTX) stock has failed to impress since Jim Cramer expressed caution - MSN
Viking Therapeutics, Inc. (NASDAQ:VKTX) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
How (VKTX) Movements Inform Risk Allocation Models - Stock Traders Daily
Here's How Much $100 Invested In Viking Therapeutics 10 Years Ago Would Be Worth Today - Sahm
[ARS] Viking Therapeutics, Inc. SEC Filing - Stock Titan
[DEF 14A] Viking Therapeutics, Inc. Definitive Proxy Statement - Stock Titan
Viking Therapeutics, Inc. (VKTX) declines more than market: Some information for investors - MSN
43,152 Shares in Viking Therapeutics, Inc. $VKTX Purchased by Royal Fund Management LLC - MarketBeat
2 Healthcare Stocks Wall Street Analysts Say Could Rally 60% or More - AOL.com
A Look At Viking Therapeutics (VKTX) Valuation As VANQUISH 2 Enrollment Milestone Advances VK2735 Program - Sahm
Viking Therapeutics, Inc. (VKTX) Declines More Than Market: Some Information for Investors - Yahoo Finance Singapore
2.69%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):